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Recently, it has been shown that human B lymphocytes possess a polymorphic 
antigen system distinct from the HLA system present on both T and B lympho- 
cytes (1-4).  These B-cell antigens  are also present on cultured lymphoblastoid 
lines (1, 3, 5, 6), acute lymphoblastic leukemia cells (7), and chronic lymphoblas- 
tic leukemia cells (1 and footnote 1). 
Earlier we described four distinct B-lymphocyte specificities which appeared 
to  belong  to  one  allelic  system  and  which  were  distinct  from  HLA  (8).  The 
present study represents a refinement of those groups with multiple sera that 
are highly associated within each specificity. Evidence for allelism by fit in the 
Hardy-Weinberg equilibrium is also provided here. 
Materials  and Methods 
B-cell-enriched  and  T-cell-enriched  lymphocyte  populations  were  isolated  from  59  normal 
unrelated Caucasians. The method used has been described in detail elsewhere. 2 Briefly, lympho- 
cytes were isolated from heparinized blood by Ficoll-Hypaque density gradient centrifugation. The 
B  cells were isolated by rosette formation of the T cells with neuraminidase-treated sheep blood 
cells and relayering on Ficoll-Hypaque. After centrifugation the rosetted T cells sedimented to the 
bottom of the tube and the B cells remained at the interface. The T cells were recovered by lysis of 
the  sheep  red  cells  with  hypotenic  Hanks'  Balanced  Salt  Solution.  The  proportion  of the  B 
lymphocytes  in  the  B-cell-enriched population  of some  samples  was  measured  by  fluorescent 
staining of surface immunoglobulin using polyvalent rabbit antihuman immunoglobulin. The B- 
cell-enriched and T-cell-enriched lymphocyte suspensions were adjusted to 1.5 × 10e/ml in McCoy's 
medium. 
The microcytotoxic test was performed by adding 1/~1 of serum to 1 pl of cell suspension (1,500 
cells) in a  microtest plate. The mixture was incubated at room temperature for 30 min. 5  ~1 of 
pooled rabbit complement was added, and incubation was carried out at room temperature for an 
additional 3 h. The reaction was then stained, fixed, and read for cytetexicity. 
The serum  samples  used to identify the B-cell specificities were obtained from multiparous 
women.  Initially over 400  serum  samples  were  screened  for B-cell  antibodies.  The 32  serum 
samples described in this report were selected from those in the initial screening program.  The 
majority of the sera contained HLA antibodies. Removal of such antibodies was performed by two 
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absorptions  of each  serum  sample  with  an  equal  amount of pooled  packed  platelets.  Each 
absorption was carried out at room temperature for 60  min. The specificities described in this 
report were derived from Mickey's Boolean analysis. 
Results 
The  32  serum  samples  used to  define  11  specificities  did  not react  with  T 
lymphocytes after platelet absorption, indicating lack of HLA antibodies. Reac- 
tivity with the B-cell-enriched lymphocyte suspensions varied from 0% kill to 
approximately 95% kill. Killing of 35-95% of the cells was considered a positive 
reaction. Fluorescence staining of surface immunoglobulin showed that between 
30 and 70% of the cells in the B-cell-enriched fraction were B cells. Rerosetting 
with neuraminidase-treated  sheep red blood cells showed less than 10% to be T 
cells. 
The antigen and gene frequencies of the 11 specificities and the number of sera 
used to define each specificity are given in Table I. The terminology used here 
for specificity assignment is the same as that used for HLA specificities. "Main" 
specificities  are  designated  by a  number,  and  closely associated  or  included 
specificities  are  given  the  same  number  followed by a  decimal  progression. 
Group 1 has the highest frequency (50.8%)  and group 2.2 the lowest (3.4%).  Five 
specificities  (1-5)  were defined by multiple  serum samples.  The coefficient of 
correlation values among the sera within each group are given in Table II. The 
correlation  coefficients  are  generally  quite  high,  in  the  range  of 0.55-0.90. 
Certain  exceptions were seen,  and these in some cases could be attributed to 
duospecific antibodies. For example, serum 3 in group 3 appeared to also contain 
anti-2,  and serum 3 in group 5 also reacted with group 2. The five specificities 
were further analyzed to determine the number of genetic loci needed for their 
expression. Fig. 1 gives the phenotypic distribution of these five specificities in 
59 unrelated Caucasians.  Two sets of triplets were found, one cell having 1, 2, 
and 3 and the other 2, 3, and 4.10 cells did not have any of the five specificities. 
TABLE  I 
Antigen and Gene Frequencies  of B-Cell Specificities  in 59 
Unrelated  Caucasians 
Group  No. Sera  Frequency  Gene frequency 
% 
1  3  50.8  0.299 
2  4  22.0  0.117 
3  4  16.9  0.O88 
4  5  16.9  0.088 
5  5  11.9  0.061 
1.1  4  32.2  0.177 
1.2  1  22.0  0.117 
2.1  1  10.2  0.052 
2.2  2  3.4  0.017 
3.1  1  13.6  0.070 
6  1  10.2  0.052 
The main B-cell  groups are designated by a number and closely  associ- 
ated or included groups are given the same number followed by a 
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TABLE  II 
Coefficient Values ( × 100) Among the Sera Defining Each of the Five Groups. Values of 
30 or Greater Indicate a Significant Correlation (P value  < 0.05) 
Sera  1  2  3  4  5  Sera  1  2  3  4  5 
Group 1  Group 4 
1  76  66  1  72  90  48  72 
2  48  2  72  72  63 
3  3  41  80 
4  35 
Group 2  5 
1  67  54  53  63 
2  60  75  77  Group 5 
3  68  73  1  46  26  41  40 
4  82  2  19  54  54 
5  3  26  35 
4  54 
5  Group 3 
1  85  37  54 
2  49  46 
3  24 
4 
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Fro.  1.  Distribution of B-lymphocyte groups in 59  unrelated Caucasians. Two sets of 
"triplets" were found, each marked by an asterisk. Each bar represents individuals  possess- 
ing the particular B-lymphocyte group given at the top of the figure. 49 of the 59 individuals 
studied could be typed for at least one of the five groups. 
Goodness of fit of the five specificities into one allelic system was estimated by 
the  Hardy-Weinberg  equilibrium  analysis  (Table  III).  The  X 2 value  for  the 
comparison of the number expected and observed for each phenotype was in each 
case less than 3.8. Furthermore, the total X 2 value, utilizing  all phenotypes, was 984  TING  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TASLE III 
Distribution of Phenotypes in 59 Unrelated  Caucasians 
Phenotype  No. expected  No. observed  X ~ value 
1,  -  17.5  18  0 
1,  2  4.1  7*  2.1 
1,  3  3.1  3  0 
1,  4  3.1  0  3.1 
1,  5  2.1  2  0 
2,  -  5.6  2  2.3 
2,  3  1.2  25  0.5 
2,  4  1.2  1  0 
2,  5  0.8  1  0.1 
3,  -  4.1  3  0.3 
3,  4  0.9  1  0 
3,  5  0.6  0  0.6 
4,  -  4.1  5  0.2 
4,  5  0.6  2  3.3 
5,  -  2.7  2  0.2 
,  7.1  10  1.2 
58.8  59  13.9 
P  >  0.18; degrees of freedom (df)  =  10. 
* One cell 1, 2, 3 (treated as 1.2). 
,  One cell 2, 3, 4 (treated  as 2.3). 
13.9  with a  P  value of greater than  0.18.  These results  indicate that  the five 
specificities could fit as an allelic system controlled by one genetic locus.  The 
gene frequencies of the five specificities total 0.653, indicating that there are still 
a  large number of alleles to be defined. 
Certain  specificities appear to be included in other specificities.  Groups 1.1 
and  1.2  are almost completely included in group  1,  although  there  were four 
exceptions. Group 2.2 is included in group 2.1, and both are completely included 
in group 2. Group 3.1 is included in group 3 with one exception. These serologic 
inclusions indicate that the "broad specificities," 1, 2,  and 3 may be split into 
smaller components, and this inclusion phenomenon is similar to that encoun- 
tered in HLA serology. Partial inclusion of groups 1 and 1.1 may also indicate 
splits,  with the reactions that do not fit representing technical errors or addi- 
tional  antibodies.  On the other hand,  the partial  inclusions may indicate the 
existence of more than one genetic locus and a high degree of linkage disequilib- 
rium  between  certain  specificities  as  in  HLA,  e.g.,  HLA-A1  and  HLA-BS, 
HLA-BW35 and HLA-CW4. It can not be discounted that the "short" groups are 
caused by weakly reacting sera. 
The  association  among  the  B-cell  specificities  and  HLA  specificities  was 
analyzed. No significant associations were seen. The highest was between group 
1.1 and HLA-BW38 (r value of 0.14).  However, it must be pointed out that the 
number of cells possessing certain  B-cell specificities was small,  and perhaps 
associations may become more apparent with larger numbers of cases. 
Discussion 
With the recent demonstration of excess antigenic reactivity with B lympho- TING  ET  AL.  BRIEF  DEFINITIVE  REPORT  985 
cytes (1-4) it is important to establish the specificities found on B lymphocytes, 
much as the HLA antigens have been defined. We have demonstrated here that 
typing for B  specificities  can  be  carried  out  in  a  relatively simple  way by 
methodology already developed for the HLA system. The basic microlymphocyte 
cytotoxicity test was modified only by increasing the incubation time from 1.5 h 
to 3.5 h. Actually, the time can be shortened to the standard 1.5 hours, although 
relatively fewer sera would be suitable as reagents because of loss of sensitivity. 
The principal technical difficulty encountered has been in the preparation of 
the  B  lymphocytes. Although  the  preparations  are  often not ideal  and  the 
surface immunoglobulin in staining cells are between 30 and 70%,  by reroset- 
ting, 90% of the cells can be shown to be non-T cells. Despite the problem that 
the B-cell preparations are probably contaminated with null cells and mono- 
cytes, it has been our experience that many of the positive reactions obtained 
show 90% of the test cells killed. Weak reactions in which a low preparation of 
cells are killed by all of the antisera are found in poor preparations with high T- 
cell contamination. By strict monitoring of the B-cell suspension to eliminate T 
cells, strong "B-cell" reactions in which 80-90% of cells are killed can routinely 
be obtained. 
We attribute the increase in correlation coefficients among sera of the same 
specificity found in this study over the previous one (8) to the higher quality of 
non-T cells  isolated  and  the  ensuing stronger reactions  obtained.  With  the 
procurement of multiple serum samples for each specificity from different do- 
nors,  greater confidence can be  attached to the validity and stability of the 
specificities defined. 
With respect to the relationship of the B-lymphocyte specificities to HLA, no 
significant association has been found in this series or in the previous one (8). 
Thus,  although the original  serum samples contained HLA antibodies,  aiq~r 
absorption  with platelets,  the remaining antibodies active against B  cells no 
longer have HLA specificities.  This does not mean, however, that the B-cell 
antigens are not determined by the HLA chromosome. Family studies are now 
being performed to examine this important point. 
Summary 
Human B  lymphocytes have been shown to have at least five polymorphic 
specificities defined by 32 antisera. The antisera were produced by absorption 
with pooled platelets to remove HLA activity and were selected out of over 400 
tested sera.  The sera that defined the five specificities had high correlation 
coefficients within a group (generally in the range of 0.6-0.9). As shown by the 
fit in the Hardy-Weinberg equilibrium, the five specificities appear to be deter- 
mined by alleles at one genetic locus. No association between these specificities 
and HLA was noted. 
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